CSI Market
Sign In | Register

Acorda Therapeutics Inc (ACORQ) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access ACORQ Annual Income Statement →
From Acorda Therapeutics Inc through Mar 31 2023, changes in Mar 31 2024's revenue and cost structure provide insight into profitability trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2024)
Q1 2024 		(Dec 31 2023) (Sep 30 2023) (Jun 30 2023) (Mar 31 2023)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax20.29
Total Revenue20.29
Costs & Expenses
Cost of Goods and Services Sold3.71
Gross Profit16.58
Selling, Administration, Marketing28.37
Depreciation & Amortization0.64
Research and Development Expense0.95
Restructuring, Accretion & Impairment Charges0.00
Other Operating Expense / -Income6.24
Total operating costs including COS39.92
Operating income / -loss-19.63
Interest Expense8.44
Net Interest Expense / -Income8.44
Extinguishment of Debt0.00
Investment Income, Interest0.21
Foreign Currency Transaction Gain (Loss), Realized-0.57
Other loss / -income-0.22
Total costs & expenses47.57
Income & Taxes
Income / -loss before income taxes-27.28
Income taxes expenses / -benefit0.11
Income after income taxes-27.40
Net income / -loss of other equity0.00
Income / -loss from continuing operations-27.40
Net income / -loss-27.40
Income / -loss to shareholder-27.40
EBIT-18.85
EBITD-17.96
EBITDA-12.63
Earnings Per Share
Basic EPS (excl. extra items)-22.06
Basic Net EPS-22.06
Basic shares outstanding (Mill. of Units)1.24
Diluted Net EPS-22.06
Diluted average shares (Mill. of Units)1.24
4 historic quarters locked

Sign in to unlock the full Acorda Therapeutics Inc income statement history.

Sign In Create Free Account

About Acorda Therapeutics Inc Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.